These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7014044)

  • 1. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
    Skakkebaek NE; Bancroft J; Davidson DW; Warner P
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):49-61. PubMed ID: 7014044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
    Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
    Nieschlag E; Büchter D; Von Eckardstein S; Abshagen K; Simoni M; Behre HM
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):757-63. PubMed ID: 10619981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural effects of testosterone undecanoate in adult men with Klinefelter's syndrome: a controlled study.
    Wu FC; Bancroft J; Davidson DW; Nicol K
    Clin Endocrinol (Oxf); 1982 May; 16(5):489-97. PubMed ID: 7083601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.
    O'Carroll R; Shapiro C; Bancroft J
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):527-38. PubMed ID: 3910302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of testosterone replacement therapy in hypogonadal men.
    Conway AJ; Boylan LM; Howe C; Ross G; Handelsman DJ
    Int J Androl; 1988 Aug; 11(4):247-64. PubMed ID: 3139571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and sexual behaviour in women using oral contraceptives.
    Bancroft J; Davidson DW; Warner P; Tyrer G
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):327-40. PubMed ID: 6991164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen levels and sex functions in testosterone-treated hypogonadal men.
    Gooren LJ
    Arch Sex Behav; 1987 Dec; 16(6):463-73. PubMed ID: 3426390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: a pilot study.
    Dobs AS; Hoover DR; Chen MC; Allen R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):33-9. PubMed ID: 9435413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral testosterone undecanoate in hypogonadal male patients.
    Franchimont P; Kicovic PM; Mattei A; Roulier R
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):313-20. PubMed ID: 102469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.
    Luisi M; Franchi F
    J Endocrinol Invest; 1980; 3(3):305-8. PubMed ID: 7000879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial trial of slow-release testosterone microspheres in hypogonadal men.
    Burris AS; Ewing LL; Sherins RJ
    Fertil Steril; 1988 Sep; 50(3):493-7. PubMed ID: 3410101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group.
    Winters SJ; Atkinson L
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):317-22. PubMed ID: 9373453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone undecanoate: a new orally active androgen.
    Hirschhäuser C; Hopkinson CR; Sturm G; Coert A
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):179-87. PubMed ID: 1098350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which testosterone replacement therapy?
    Cantrill JA; Dewis P; Large DM; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):97-107. PubMed ID: 6467640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial.
    Wang C; Harnett M; Dobs AS; Swerdloff RS
    J Androl; 2010; 31(5):457-65. PubMed ID: 20133964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.